Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Metro Healthcare BhdXKLS:0329 +2.27%55 5-Year Yield-on-Cost % is 8.24 as of Jul. 25, 2026, which is 27% below its 10-year median of 11.28. GuruFocus rates XKLS:0329 with a GF Score™ of 55/100 and a GF Value™ of RM0.31 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 277 Healthcare Providers & Services companies, Metro Healthcare Bhd ranks better than 89.53% on this metric.
Metro Healthcare Bhd's yield on cost for the quarter that ended in Mar. 2026 was 8.24.
The historical rank and industry rank for Metro Healthcare Bhd's 5-Year Yield-on-Cost % or its related term are showing as below:
XKLS:0329'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 6.17 Med: 11.28 Max: 18.14
Current: 8.24
During the past 11 years, Metro Healthcare Bhd's highest Yield on Cost was 18.14. The lowest was 6.17. And the median was 11.28.
XKLS:0329's 5-Year Yield-on-Cost % is ranked better than 89.53% of 277
companies
in the Healthcare Providers & Services industry
Industry Median: 2.9
vs XKLS:0329: 8.24
Metro Healthcare Bhd (XKLS:0329) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Metro Healthcare Bhd 5-Year Yield-on-Cost % Related Terms
XKLS:0329 vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Metro Healthcare Bhd's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metro Healthcare Bhd 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Metro Healthcare Bhd's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Metro Healthcare Bhd's 5-Year Yield-on-Cost % falls into.
Metro Healthcare Bhd 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Metro Healthcare Bhd (XKLS:0329) has a 5-Year Yield-on-Cost % of 8.24 as of Jul. 25, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Metro Healthcare Bhd and its competitors. This is 27% below median its historical median of 11.28. Over the past decade, Metro Healthcare Bhd's 5-Year Yield-on-Cost % has ranged from 6.17 to 18.14. According to the industry distribution chart, Metro Healthcare Bhd ranks #29 out of 277 companies in the Healthcare Providers & Services industry, placing it in the top 10.5%.
Is Metro Healthcare Bhd's 5-Year Yield-on-Cost % too high?
Metro Healthcare Bhd's current 5-Year Yield-on-Cost % of 8.24 is 27% below median its 10-year median of 11.28. Over the past 10 years, this metric has ranged from a low of 6.17 to a high of 18.14. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.90. Metro Healthcare Bhd's value of 8.24 is 184.1% above this industry median. Based on the distribution chart, Metro Healthcare Bhd ranks #29 out of 277 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Metro Healthcare Bhd has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Metro Healthcare Bhd's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Metro Healthcare Bhd ranks #29 out of 277 companies for 5-Year Yield-on-Cost %. This places Metro Healthcare Bhd in the top 11% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.90. Metro Healthcare Bhd's value of 8.24 is 184.1% above this benchmark. Historically, Metro Healthcare Bhd's own 5-Year Yield-on-Cost % has ranged from 6.17 to 18.14 over the past decade. While the company's 10-year median is 11.28 vs. the industry median of 2.90, Metro Healthcare Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.90, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Metro Healthcare Bhd's current 5-Year Yield-on-Cost % of 8.24 is 184.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Metro Healthcare Bhd and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metro Healthcare Bhd's current 5-Year Yield-on-Cost % is 8.24, which is 27% below median its own 10-year median of 11.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metro Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Metro Healthcare Bhd (XKLS:0329) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.31, compared to a current price of RM0.23 — trading 27.4% below its estimated fair value. The current 5-Year Yield-on-Cost % is 8.24, which is 27% below median its 10-year median of 11.28 and 184.1% above the Healthcare Providers & Services industry median of 2.90. Metro Healthcare Bhd's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Metro Healthcare Bhd (XKLS:0329), the current 5-Year Yield-on-Cost % is 8.24 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Metro Healthcare Bhd (XKLS:0329) Overvalued in 2026?
Based on GuruFocus' analysis, Metro Healthcare Bhd stock appears to be undervalued.
The current stock price of RM0.23 is trading 27.4% below its estimated GF Value™ of RM0.31.
GuruFocus considers Metro Healthcare Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0329:
5-Year Yield-on-Cost %: 8.24 (27% below median its 10-year median of 11.28)
GF Value™: RM0.31 vs. price of RM0.23 (27.4% below fair value)
Industry Position: 184.1% above the Healthcare Providers & Services median (#29 of 277)
No single metric tells the full story. See the XKLS:0329 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Metro Healthcare Bhd is engaged in the provision of women healthcare services. The company offers various services such as obstetrics, gynecology impatient services, and diagnostic medical imaging services. It also provides semen analysis, intracytoplasmic sperm injection, blastocyst culture, assisted hatching, frozen embryo transfer, preimplantation genetic screening, and infertility consultation services. The company serves patients in Malaysia. The firm's business segment includes O&G healthcare services, Complementary services, and Hospital services.
55GF Score
Get the complete analysis for XKLS:0329
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0329 has been successfully added to your 
